Marvell, Lumentum tout historic $115B deal to create ‘category leader’ in AI connectivity
Marvell CEO Matt Murphy calls the $115 billion Lumentum acquisition a once-in-a-generation move to create a dominant AI connectivity leader.
AI expert Gary Marcus warns 'reckless' technology could lead to deaths as he calls for more regulation
NYU Professor Emeritus Gary Marcus warns AI will cause loss of life, saying the White House's self-policing approach leaves infrastructure vulnerable.
Nvidia CEO Jensen Huang rips 'the Band-Aid off' as AI chip giant resets expectations
Nvidia CEO Jensen Huang says the company decided to "rip the Band-Aid off" on gross margins, resetting expectations to 72%-73% for next year.
California Pizza Kitchen co-founder opens up about famous chain's wild rise, bankruptcy and comeback
Rick Rosenfield reveals how Golden Gate Capital damaged CPK's culture before the pizza chain's Chapter 11 bankruptcy filing from its Beverly Hills origins.
Zoox CEO says autonomous vehicles need regulation months after robotaxi drove into Las Vegas fire scene
Zoox CEO Aicha Evans told FOX Business the Amazon robotaxi needs regulation after a vehicle drove into heavy smoke at an emergency scene in in Las Vegas.
Burger chain bucks California trend, doubles down on Golden State despite rising costs
Freddy's Frozen Custard & Steakburgers CEO says California gets a "bad rap" as competitors close doors, planning 60 new locations nationwide this year with a Northern California focus.
Palantir CEO warns US against Europe's AI regulation path, urges Trump admin to not ban open models
Palantir CEO Alex Karp warns the Trump administration against adopting Europe-style AI regulation, saying the continent has 'regulated itself out of business.'
IMAX CEO describes 'frenzy' after Christopher Nolan's 'The Odyssey' shatters records
IMAX CEO Rich Gelfond calls Christopher Nolan's 'The Odyssey' movie premiere a 'frenzy' after the action epic raked in over $124 million in ticket sales on its box office debut weekend.
Tom Brady teams with digital health firm eMed to expand GLP-1 weight loss medication access
NFL legend Tom Brady is partnering with eMed to tackle the obesity epidemic by making GLP-1 weight loss medications accessible through employer health benefits.









